Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A
- PMID: 3290383
- PMCID: PMC2189674
- DOI: 10.1084/jem.167.6.1945
Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A
Abstract
We present a model in which animals are passively immunized at a mucosal site, allowing one to evaluate immunological protection at the mucosal level only. Affinity-purified, anti-M protein sIgA administered intranasally protected mice against systemic infection after intranasal challenge with group A streptococci. In contrast, anti-M protein serum Ig administered intranasally was not protective at this site, although it neutralized the antiphagocytic property of M protein and promoted phagocytosis. Protection by sIgA occurred despite the lower immunoreactivity of sIgA to purified M protein compared with serum Ig. The data suggest that sIgA can protect at the mucosa and may preclude the need for opsonic IgG in preventing streptococcal infection.
Similar articles
-
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.Infect Immun. 1988 Oct;56(10):2666-72. doi: 10.1128/iai.56.10.2666-2672.1988. Infect Immun. 1988. PMID: 2458320 Free PMC article.
-
Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.J Infect Dis. 2011 Jun 1;203(11):1595-601. doi: 10.1093/infdis/jir149. J Infect Dis. 2011. PMID: 21592989 Free PMC article.
-
Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.Infect Immun. 1998 Mar;66(3):974-9. doi: 10.1128/IAI.66.3.974-979.1998. Infect Immun. 1998. PMID: 9488384 Free PMC article.
-
Role of secretory antibodies in the defence against infections.Int J Med Microbiol. 2003 Apr;293(1):3-15. doi: 10.1078/1438-4221-00241. Int J Med Microbiol. 2003. PMID: 12755363 Review.
-
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.J Immunol. 2017 Jul 1;199(1):9-16. doi: 10.4049/jimmunol.1601775. J Immunol. 2017. PMID: 28630108 Free PMC article. Review.
Cited by
-
Plant antibodies for immunotherapy.Plant Physiol. 1995 Oct;109(2):341-6. doi: 10.1104/pp.109.2.341. Plant Physiol. 1995. PMID: 7480334 Free PMC article. Review.
-
Oral microbial ecology and the role of salivary immunoglobulin A.Microbiol Mol Biol Rev. 1998 Mar;62(1):71-109. doi: 10.1128/MMBR.62.1.71-109.1998. Microbiol Mol Biol Rev. 1998. PMID: 9529888 Free PMC article. Review.
-
Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.PLoS One. 2020 Jun 23;15(6):e0235139. doi: 10.1371/journal.pone.0235139. eCollection 2020. PLoS One. 2020. PMID: 32574205 Free PMC article.
-
Host Pathways of Hemostasis that Regulate Group A Streptococcus pyogenes Pathogenicity.Curr Drug Targets. 2020;21(2):193-201. doi: 10.2174/1389450120666190926152914. Curr Drug Targets. 2020. PMID: 31556853 Free PMC article.
-
A Quorum Sensing-Regulated Protein Binds Cell Wall Components and Enhances Lysozyme Resistance in Streptococcus pyogenes.J Bacteriol. 2018 May 9;200(11):e00701-17. doi: 10.1128/JB.00701-17. Print 2018 Jun 1. J Bacteriol. 2018. PMID: 29555699 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical